Showing results (251-260 of 384) with videos related to
Sort By:
Pageof 39
International Journal of Oncology|December 17, 2008
Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2Javier A Menendez, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.International Journal of Oncology|December 4, 2009
Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsiesEugeni Lopez-Bonet, Alejandro Vazquez-Martin, Maria Carmen Pérez-Martínez, et al.Endocrine Research|January 1, 1988
Harderian gland N-acetyltransferase activity in the male Syrian hamster: effects of gonadectomy, short photoperiod exposure, or subcutaneous melatonin implantsA Menendez-Pelaez, R J Reiter, K A Howes, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 28, 2026
Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturationEduard Teixidor-Vilà, José Antonio Encinar, Begoña Martin-Castillo, et al.The Journal of Pediatrics|March 4, 2000
Pulmonary infiltrates with eosinophilia syndromes in childrenC M Oermann, K S Panesar, C Langston, et al.Biochemical and Biophysical Research Communications|May 18, 2010
Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Begoña Martin-Castillo, et al.Oncotarget|April 8, 2017
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cellsElisabet Cuyàs, Bruna Corominas-Faja, María Muñoz-San Martín, et al.Cell Cycle (Georgetown, Tex.)|February 16, 2012
Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformationCristina Oliveras-Ferraros, Sílvia Cufí, Alejandro Vazquez-Martin, et al.Oncotarget|December 29, 2011
Metformin: multi-faceted protection against cancerSonia Del Barco, Alejandro Vazquez-Martin, Sílvia Cufí, et al.Cancer & Metabolism|May 4, 2019
Stratification of cancer and diabetes based on circulating levels of formate and glucoseMatthias Pietzke, Salvador Fernandez Arroyo, David Sumpton, et al.Pageof 39